Generally, AR is over-expressed and the AR signalling pathway is extraordinarily activated in androgen-responsive prostate cancer cells; by contrast, the expression of AR is extremely low in androgen-irresponsive prostate cancer cells and the growth and proliferation of these cells is independent of AR. This evidence concerns the gene AR and prostate cancer.